3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
4
Nasopharyngeal Carcinoma
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Meningioma
2
Liver Neoplasms
2
HER2-positive Breast Cancer
2
Glioma
2
Glioblastoma
2
Chordoma
2
Carcinoma, Hepatocellular
2
Carcinoma, Adenoid Cystic
2
Brain Neoplasms
2
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Radiation Injuries
1
Pituitary Neoplasms
1
Oligodendroglioma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Interventions
Radiotherapy
29
Cisplatin
12
Amifostine
11
Radiotherapy, Intensity-Modulated
7
Paclitaxel
7
Carboplatin
7
Etoposide
5
Radiosurgery
4
Donepezil
4
Brachytherapy
4
Bevacizumab
4
sargramostim
3
Surgical Procedures, Operative
3
Mental Status and Dementia Tests
3
Filgrastim
3
Diet Therapy
3
Blood Specimen Collection
3
Radiation Dose Hypofractionation
2
Radiation
2
Proton Therapy
2
Magnetic Resonance Spectroscopy
2
Low-Level Light Therapy
2
Lithium
2
Hyperbaric Oxygenation
2
Heavy Ion Radiotherapy
2
Fluorouracil
2
Fibroblast Growth Factor 7
2
Dexamethasone
2
Chemotherapy, Adjuvant
2
Androgen Antagonists
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Radiation Injuries
×
Protons
×
Clear all
NCT05548504
2022-09-21
HERAN2
Odense University Hospital
Phase 2
Not yet recruiting
182 enrolled